Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

EPH Receptor A7 anticorps (AA 28-182) (HRP)

Cet anticorps anti-EPH Receptor A7 est un anticorps Lapin Polyclonal détectant EPH Receptor A7 dans ELISA. Adapté pour Humain.
N° du produit ABIN7151854

Aperçu rapide pour EPH Receptor A7 anticorps (AA 28-182) (HRP) (ABIN7151854)

Antigène

Voir toutes EPH Receptor A7 (EPHA7) Anticorps
EPH Receptor A7 (EPHA7)

Reactivité

  • 66
  • 31
  • 31
  • 5
  • 5
  • 4
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Humain

Hôte

  • 62
  • 4
  • 1
Lapin

Clonalité

  • 63
  • 4
Polyclonal

Conjugué

  • 28
  • 6
  • 6
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp EPH Receptor A7 est conjugé à/à la HRP

Application

  • 48
  • 30
  • 23
  • 19
  • 13
  • 13
  • 9
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
ELISA
  • Épitope

    • 16
    • 9
    • 8
    • 7
    • 5
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 28-182

    Fonction

    EPHA7 Antibody, HRP conjugated

    Purification

    Protein G purified

    Pureté

    >95 %

    Immunogène

    Recombinant Human Ephrin type-A receptor 7 protein (28-182AA)

    Isotype

    IgG
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène

    EPH Receptor A7 (EPHA7)

    Autre désignation

    EPHA7

    Sujet

    Background: Receptor tyrosine kinase which binds promiscuously GPI-anchored ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Among GPI-anchored ephrin-A ligands, EFNA5 is a cognate/functional ligand for EPHA7 and their interaction regulates brain development modulating cell-cell adhesion and repulsion. Has a repellent activity on axons and is for instance involved in the guidance of corticothalamic axons and in the proper topographic mapping of retinal axons to the colliculus. May also regulate brain development through a caspase(CASP3)-dependent proapoptotic activity. Forward signaling may result in activation of components of the ERK signaling pathway including MAP2K1, MAP2K2, MAPK1 AND MAPK3 which are phosphorylated upon activation of EPHA7.

    Aliases: Cek 11 antibody, Developmental kinase 1 antibody, EBK antibody, EHK-3 antibody, EHK3 antibody, EK11 antibody, Embryonic brain kinase antibody, EPH homology kinase 3 antibody, EPH-like kinase 11 antibody, Epha7 antibody, EPHA7_HUMAN antibody, Ephrin receptor Eph A7 antibody, Ephrin type A receptor 7 antibody, Ephrin type-A receptor 7 antibody, hEK11 antibody, MDK 1 antibody, Receptor protein tyrosine kinase HEK 11 antibody, Tyrosine protein kinase receptor EHK 3 antibody

    UniProt

    Q15375

    Pathways

    Signalisation RTK
Vous êtes ici:
Chat with us!